Risk-adapted treatment and follow-up management in childhood-onset craniopharyngioma

References

• Müller HL. Craniopharyngioma – pediatric management. In: Jj E, Tj K, editors. Craniopharyngiomas – comprehensive diagnosis, treatment and outcome. 1st ed. Munich, Germany: Elsevier; 2015. p. 429–458.
   Google Scholar
• Muller HL. Childhood craniopharyngioma–current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol. 2010;6:609–618.
   PubMed Web of Science ®Google Scholar
• Muller HL. Paediatrics: surgical strategy and quality of life in craniopharyngioma. Nat Rev Endocrinol. 2013;9:447–449.
   PubMed Web of Science ®Google Scholar
• Muller HL. Craniopharyngioma. Endocr Rev. 2014;35:513–543.
   PubMed Web of Science ®Google Scholar
• Daubenbuchel AM, Muller HL. Neuroendocrine disorders in pediatric craniopharyngioma patients. J Clin Med. 2015;4:389–413.
   PubMed Web of Science ®Google Scholar
• Muller HL. Preoperative staging in childhood craniopharyngioma: standardization as a first step towards improved outcome. Endocrine. 2016;51:1–3.
   PubMed Web of Science ®Google Scholar
• Muller HL. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes. 2016;23:81–89.
   PubMed Web of Science ®Google Scholar
• Muller HL. Craniopharyngioma. Handb Clin Neurol. 2014;124:235–253.
   PubMedGoogle Scholar
• Bereket A, Kiess W, Lustig RH, et al. Hypothalamic obesity in children. Obes Rev: Off J Int Assoc Study Obes. 2012;13:780–798.
   PubMed Web of Science ®Google Scholar
• Tomlinson JW, Holden N, Hills RK, et al. Association between premature mortality and hypopituitarism. West Midlands prospective hypopituitary study group. Lancet. 2001;357:425–431.
   PubMed Web of Science ®Google Scholar
• Muller HL. Diagnostics, treatment, and follow-up in craniopharyngioma. Front Endocrinol (Lausanne). 2011;2:70.
   PubMedGoogle Scholar
• Muller HL. Childhood craniopharyngioma. Pituitary. 2013;16:56–67.
   PubMed Web of Science ®Google Scholar
• Sterkenburg AS, Hoffmann A, Gebhardt U, et al. Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro-oncology. 2015;17:1029–1038.
   PubMed Web of Science ®Google Scholar
• Nielsen EH, Feldt-Rasmussen U, Poulsgaard L, et al. Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol. 2011;104:755–763.
   PubMed Web of Science ®Google Scholar
• Bunin GR, Surawicz TS, Witman PA, et al. The descriptive epidemiology of craniopharyngioma. J Neurosurg. 1998;89:547–551.
   PubMed Web of Science ®Google Scholar
• Muller-Scholden J, Lehrnbecher T, Muller HL, et al. Radical surgery in a neonate with craniopharyngioma. report of a case. Pediatr Neurosurg. 2000;33:265–269.
   PubMed Web of Science ®Google Scholar
• Larkin SJ, Ansorge O. Pathology and pathogenesis of craniopharyngiomas. Pituitary. 2013;16:9–17.
   PubMed Web of Science ®Google Scholar
• Rushing EJ, Giangaspero F, Paulus W, et al. Craniopharyngioma. In: Louis DN, Ohgaki H, Wiestler OD, et al., editors. WHO classification of tumours of the central nervous system. 3rd ed. Geneva: WHO Press; 2007.
   Google Scholar
• Warmuth-Metz M, Gnekow AK, Muller H, et al. Differential diagnosis of suprasellar tumors in children. Klin Padiatr. 2004;216:323–330.
   PubMed Web of Science ®Google Scholar
• Boch AL, van Effenterre R, Kujas M. Craniopharyngiomas in two consanguineous siblings: case report. Neurosurgery. 1997;41:1185–1187.
   PubMed Web of Science ®Google Scholar
• Green AL, Yeh JS, Dias PS. Craniopharyngioma in a mother and daughter. Acta Neurochir (Wien). 2002;144:403–404.
   PubMed Web of Science ®Google Scholar
• Kordes U, Flitsch J, Hagel C, et al. Ectopic craniopharyngioma. Klin Padiatr. 2011;223:176–177.
   PubMed Web of Science ®Google Scholar
• Muller HL, Kaatsch P, Warmuth-Metz M, et al. Childhood craniopharyngioma - diagnostic and therapeutic strategies. Monatsschr Kinderheilkd. 2003;151:1056–1063.
   Web of Science ®Google Scholar
• Sherlock M, Ayuk J, Tomlinson JW, et al. Mortality in patients with pituitary disease. Endocr Rev. 2010;31:301–342.
   PubMed Web of Science ®Google Scholar
• Garre ML, Cama A. Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr Opin Pediatr. 2007;19:471–479.
   PubMed Web of Science ®Google Scholar
• Kato K, Nakatani Y, Kanno H, et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol. 2004;203:814–821.
   PubMed Web of Science ®Google Scholar
• Buslei R, Holsken A, Hofmann B, et al. Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol. 2007;113:585–590.
   PubMed Web of Science ®Google Scholar
• Gaston-Massuet C, Andoniadou CL, Signore M, et al. Increased wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans. Proc Natl Acad Sci U S A. 2011;108:11482–11487.
   PubMed Web of Science ®Google Scholar
• Andoniadou CL, Gaston-Massuet C, Reddy R, et al. Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma. Acta Neuropathol. 2012;124:259–271.
   PubMed Web of Science ®Google Scholar
• Brastianos PK, Taylor-Weiner A, Manley PE, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46:161–165.
   PubMed Web of Science ®Google Scholar
• Brastianos PK, Shankar GM, Gill CM, et al. 2nd 2016 dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy. J Natl Cancer Inst. 2015;108(2). pii: djv310. doi:10.1093/jnci/djv310. PMID: 26498373.
   PubMedGoogle Scholar
• Muller HL, Bueb K, Bartels U, et al. Obesity after childhood craniopharyngioma–German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr. 2001;213:244–249.
   PubMed Web of Science ®Google Scholar
• Muller HL, Heinrich M, Bueb K, et al. Perioperative dexamethasone treatment in childhood craniopharyngioma–influence on short-term and long-term weight gain. Exp Clin Endocrinol Diabetes. 2003;111:330–334.
   PubMed Web of Science ®Google Scholar
• Muller HL. Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res. 2008;69:193–202.
   PubMedGoogle Scholar
• Elliott RE, Jane JA Jr., Wisoff JH. Surgical management of craniopharyngiomas in children: meta-analysis and comparison of transcranial and transsphenoidal approaches. Neurosurgery. 2011;69:630–643. discussion 643
   PubMed Web of Science ®Google Scholar
• Muller HL, Emser A, Faldum A, et al. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab. 2004;89:3298–3305.
   PubMed Web of Science ®Google Scholar
• Hoffmann A, Boekhoff S, Gebhardt U, et al. History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis. Eur J endocrinol/Eur Fed Endocr Soc. 2015;173:853–862.
   PubMed Web of Science ®Google Scholar
• De Vile CJ, Grant DB, Kendall BE, et al. Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J Neurosurg. 1996;85:73–81.
   PubMed Web of Science ®Google Scholar
• Elowe-Gruau E, Beltrand J, Brauner R, et al. Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab. 2013;98:2376–2382.
   PubMed Web of Science ®Google Scholar
• Muller HL, Gebhardt U, Faldum A, et al. Xanthogranuloma, Rathke’s cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations. J Clin Endocrinol Metab. 2012;97:3935–3943.
   PubMed Web of Science ®Google Scholar
• Muller HL, Gebhardt U, Teske C, et al. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J endocrinol/Eur Fed Endocr Soc. 2011;165:17–24.
   PubMed Web of Science ®Google Scholar
• Mallucci C, Pizer B, Blair J, et al. Management of craniopharyngioma: the Liverpool experience following the introduction of the CCLG guidelines. Introducing a new risk assessment grading system. Childs Nerv Syst. 2012;28:1181–1192.
   PubMed Web of Science ®Google Scholar
• Van Gompel JJ, Nippoldt TB, Higgins DM, et al. Magnetic resonance imaging-graded hypothalamic compression in surgically treated adult craniopharyngiomas determining postoperative obesity. Neurosurgical Focus. 2010;28:E3.
   PubMed Web of Science ®Google Scholar
• Steno J, Bizik I, Steno A, et al. Craniopharyngiomas in children: how radical should the surgeon be? Childs Nerv Syst. 2011;27:41–54.
   PubMed Web of Science ®Google Scholar
• Elliott RE, Sands SA, Strom RG, et al. Craniopharyngioma clinical status scale: a standardized metric of preoperative function and posttreatment outcome. Neurosurgical Focus. 2010;28:E2.
   PubMed Web of Science ®Google Scholar
• Mortini P, Gagliardi F, Bailo M, et al. Magnetic resonance imaging as predictor of functional outcome in craniopharyngiomas. Endocrine. 2016;51:148–162.
   PubMed Web of Science ®Google Scholar
• Sanford RA. Craniopharyngioma: results of survey of the American society of pediatric neurosurgery. Pediatr Neurosurg. 1994;21(Suppl 1):39–43.
   PubMed Web of Science ®Google Scholar
• Boop FA. Craniopharyngioma. J Neurosurg. 2007;106:1–2; discussion 2
   PubMed Web of Science ®Google Scholar
• Muller HL. Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab. 2011;96:1981–1991.
   PubMed Web of Science ®Google Scholar
• Kortmann RD. Different approaches in radiation therapy of craniopharyngioma. Front Endocrinol (Lausanne). 2011;2:100.
   PubMedGoogle Scholar
• Aggarwal A, Fersht N, Brada M. Radiotherapy for craniopharyngioma. Pituitary. 2013;16:26–33.
   PubMed Web of Science ®Google Scholar
• Merchant TE, Kiehna EN, Kun LE, et al. Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J Neurosurg. 2006;104:94–102.
   PubMed Web of Science ®Google Scholar
• Fitzek MM, Linggood RM, Adams J, et al. Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at harvard cyclotron laboratory and massachusetts general hospital. Int J Radiat Oncol Biol Phys. 2006;64:1348–1354.
   PubMed Web of Science ®Google Scholar
• Luu QT, Loredo LN, Archambeau JO, et al. Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report. Cancer J. 2006;12:155–159.
   PubMed Web of Science ®Google Scholar
• Winkfield KM, Linsenmeier C, Yock TI, et al. Surveillance of craniopharyngioma cyst growth in children treated with proton radiotherapy. Int J Radiat Oncol Biol Phys. 2009;73:716–721.
   PubMed Web of Science ®Google Scholar
• Boehling NS, Grosshans DR, Bluett JB, et al. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas. Int J Radiat Oncol Biol Phys. 2012;82:643–652.
   PubMed Web of Science ®Google Scholar
• Beltran C, Roca M, Merchant TE. On the benefits and risks of proton therapy in pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys. 2012;82:e281–e287.
   PubMedGoogle Scholar
• Cavalheiro S, Sparapani FV, Franco JO, et al. Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. J Neurosurg. 1996;84:124–126.
   PubMed Web of Science ®Google Scholar
• Schubert T, Trippel M, Tacke U, et al. Neurosurgical treatment strategies in childhood craniopharyngiomas: is less more? Childs Nerv Syst. 2009;25:1419–1427.
   PubMed Web of Science ®Google Scholar
• Lafay-Cousin L, Bartels U, Raybaud C, et al. Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma. Report of three cases. J Neurosurg. 2007;107:318–323.
   PubMed Web of Science ®Google Scholar
• Cavalheiro S, Di Rocco C, Valenzuela S, et al. Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases. Neurosurgical Focus. 2010;28:E12.
   PubMed Web of Science ®Google Scholar
• Bartels U, Laperriere N, Bouffet E, et al. Intracystic therapies for cystic craniopharyngioma in childhood. Front Endocrinol (Lausanne). 2012;3:39.
   PubMedGoogle Scholar
• Rath SR, Lee S, Kotecha RS, et al. Childhood craniopharyngioma: 20-year institutional experience in Western Australia. J Paediatr Child Health. 2013;49:403–408.
   PubMed Web of Science ®Google Scholar
• Lo AC, Howard AF, Nichol A, et al. Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia cancer agency experience. Int J Radiat Oncol Biol Phys. 2014;88:1011–1018.
   PubMed Web of Science ®Google Scholar
• Hankinson TC, Palmeri NO, Williams SA, et al. Patterns of care for craniopharyngioma: survey of members of the american association of neurological surgeons. Pediatr Neurosurg. 2013;49:131–136.
   PubMed Web of Science ®Google Scholar
• Ha Z, Chapple K, Little AS. National treatment trends, complications, and predictors of in-hospital charges for the surgical management of craniopharyngiomas in adults from 2007 to 2011. Neurosurgical Focus. 2014;37:E6.
   Google Scholar
• Muller HL. Childhood craniopharyngioma: treatment strategies and outcomes. Expert Rev Neurother. 2014;14:187–197.
   PubMed Web of Science ®Google Scholar
• Solari D, Cavallo LM, Cappabianca P. Surgical approach to pituitary tumors. Handb Clin Neurol. 2014;124:291–301.
   PubMedGoogle Scholar
• Flitsch J, Aberle J, Burkhardt T. Surgery for pediatric craniopharyngiomas: is less more?. J Pediatr Endocrinol Metab: JPEM. 2015;28:27–33.
   PubMed Web of Science ®Google Scholar
• Buchfelder M, Schlaffer SM, Lin F, et al. Surgery for craniopharyngioma. Pituitary. 2013;16:18–25.
   PubMed Web of Science ®Google Scholar
• Mortini P, Gagliardi F, Boari N, et al. Surgical strategies and modern therapeutic options in the treatment of craniopharyngiomas. Crit Rev Oncol Hematol. 2013;88:514–529.
   PubMed Web of Science ®Google Scholar
• Ali ZS, Bailey RL, Daniels LB, et al. Comparative effectiveness of treatment options for pediatric craniopharyngiomas. J Neurosurg Pediatr. 2014;13:178–188.
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Kawaguchi T, Tominaga T. Outcome and mid-term prognosis after maximum and radical removal of craniopharyngiomas with the priority to the extended transsphenoidal approach–a single center experience. Clin Neurol Neurosurg. 2014;125:41–46.
   PubMed Web of Science ®Google Scholar
• Raza SM, Schwartz TH. How to achieve the best possible outcomes in the management of retroinfundibular craniopharyngiomas? World Neurosurg. 2014;82:614–616.
   PubMed Web of Science ®Google Scholar
• Hoffmann A, Warmth-Metz M, Gebhardt U, et al. Childhood craniopharyngioma - changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007. Klin Padiatr. 2014;226:161–168.
   PubMed Web of Science ®Google Scholar
• Flitsch J, Muller HL, Burkhardt T. Surgical strategies in childhood craniopharyngioma. Front Endocrinol (Lausanne). 2011;2:96.
   PubMedGoogle Scholar
• Patel KS, Raza SM, McCoul ED, et al. Long-term quality of life after endonasal endoscopic resection of adult craniopharyngiomas. J Neurosurg. 2015:1–10.
   Google Scholar
• Cavallo LM, Solari D, Esposito F, et al. The role of the endoscopic endonasal route in the management of craniopharyngiomas. World Neurosurg. 2014;82:S32–S40.
   PubMedGoogle Scholar
• Bailey S, Parkes J. Intracystic interferon therapy in childhood craniopharyngioma: who, when and how? Clin Endocrinol (Oxf). 2015;82:29–34.
   PubMed Web of Science ®Google Scholar
• Zheng J, Fang Y, Cai BW, et al. Intracystic bleomycin for cystic craniopharyngiomas in children. Cochrane Database Syst Rev. 2014;9:CD008890.
   PubMedGoogle Scholar
• Klimo P Jr., Venable GT, Boop FA, et al. Recurrent craniopharyngioma after conformal radiation in children and the burden of treatment. J Neurosurg Pediatr. 2015;15:499–505.
   PubMed Web of Science ®Google Scholar
• Greenfield BJ, Okcu MF, Baxter PA, et al. Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma. Radiother oncology: J Eur Soc Ther Radiol Oncol. 2015;114:224–229.
   PubMed Web of Science ®Google Scholar
• Bishop AJ, Greenfield B, Mahajan A, et al. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys. 2014;90:354–361.
   PubMed Web of Science ®Google Scholar
• Harrabi SB, Adeberg S, Welzel T, et al. Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects. Radiat Oncol. 2014;9:203.
   PubMed Web of Science ®Google Scholar
• Lee CC, Yang HC, Chen CJ, et al. Gamma Knife surgery for craniopharyngioma: report on a 20-year experience. J Neurosurg. 2014;121(Suppl):167–178.
   PubMed Web of Science ®Google Scholar
• Fjalldal S, Holmer H, Rylander L, et al. Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metab. 2013;98:3253–3262.
   PubMed Web of Science ®Google Scholar
• Steno J, Bizik I, Steno A, et al. Craniopharyngiomas and the hypothalamus. J Neurosurg. 2013;119:1646–1650.
   PubMed Web of Science ®Google Scholar
• Rosenfeld A, Arrington D, Miller J, et al. A review of childhood and adolescent craniopharyngiomas with particular attention to hypothalamic obesity. Pediatr Neurol. 2014;50:4–10.
   PubMed Web of Science ®Google Scholar
• Khan MJ, Humayun KN, Donaldson M, et al. Longitudinal changes in body mass index in children with craniopharyngioma. Horm Res Paediatr. 2014;82:372–379.
   PubMed Web of Science ®Google Scholar
• Erfurth EM. Endocrine aspects and sequel in patients with craniopharyngioma. J Pediatr Endocrinol Metab. 2015;28:19–26.
   PubMed Web of Science ®Google Scholar
• Roth CL, Eslamy H, Werny D, et al. Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity. Obesity (Silver Spring). 2015;23:1226–1233.
   PubMed Web of Science ®Google Scholar
• Muller HL. Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives. Int J Endocrinol. 2010;2010:519607.
   PubMed Web of Science ®Google Scholar
• Castro DC, Cole SL, Berridge KC. Lateral hypothalamus, nucleus accumbens, and ventral pallidum roles in eating and hunger: interactions between homeostatic and reward circuitry. Front Syst Neurosci. 2015;9:90.
   PubMed Web of Science ®Google Scholar
• Kim JH, Choi JH. Pathophysiology and clinical characteristics of hypothalamic obesity in children and adolescents. Ann Pediatr Endocrinol Metab. 2013;18:161–167.
   PubMedGoogle Scholar
• Haliloglu B, Bereket A. Hypothalamic obesity in children: pathophysiology to clinical management. J Pediatr Endocrinol Metab. 2015;28:503–513.
   PubMed Web of Science ®Google Scholar
• Cohen M, Syme C, McCrindle BW, et al. Autonomic nervous system balance in children and adolescents with craniopharyngioma and hypothalamic obesity. Eur J endocrinol/Eur Fed Endocr Soc. 2013;168:845–852.
   PubMed Web of Science ®Google Scholar
• Harz KJ, Muller HL, Waldeck E, et al. Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab. 2003;88:5227–5231.
   PubMed Web of Science ®Google Scholar
• Muller HL, Handwerker G, Gebhardt U, et al. Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness. Cancer Causes Control: CCC. 2006;17:583–589.
   PubMed Web of Science ®Google Scholar
• Muller HL, Handwerker G, Wollny B, et al. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab. 2002;87:3993–3996.
   PubMed Web of Science ®Google Scholar
• Elfers CT, Roth CL. Effects of methylphenidate on weight gain and food intake in hypothalamic obesity. Front Endocrinol (Lausanne). 2011;2:78.
   PubMedGoogle Scholar
• Bomer I, Saure C, Caminiti C, et al. Comparison of energy expenditure, body composition, metabolic disorders, and energy intake between obese children with a history of craniopharyngioma and children with multifactorial obesity. J Pediatr Endocrinol Metab. 2015;28:1305–1312.
   PubMed Web of Science ®Google Scholar
• Holmer H, Pozarek G, Wirfalt E, et al. Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. J Clin Endocrinol Metab. 2010;95:5395–5402.
   PubMed Web of Science ®Google Scholar
• Prieto R, Pascual JM, Barrios L. Optic chiasm distortions caused by craniopharyngiomas: clinical and magnetic resonance imaging correlation and influence on visual outcome. World Neurosurg. 2015;83:500–529.
   PubMed Web of Science ®Google Scholar
• Drimtzias E, Falzon K, Picton S, et al. The ophthalmic natural history of paediatric craniopharyngioma: a long-term review. J Neurooncol. 2014;120:651–656.
   PubMed Web of Science ®Google Scholar
• Roemmler-Zehrer J, Geigenberger V, Stormann S, et al. Food intake regulating hormones in adult craniopharyngioma patients. Eur J endocrinol/Eur Fed Endocr Soc. 2014;170:627–635.
   PubMed Web of Science ®Google Scholar
• Roth CL, Elfers C, Gebhardt U, et al. Brain-derived neurotrophic factor and its relation to leptin in obese children before and after weight loss. Metabolism. 2013;62:226–234.
   PubMed Web of Science ®Google Scholar
• Roth CL, Enriori PJ, Gebhardt U, et al. Changes of peripheral alpha-melanocyte-stimulating hormone in childhood obesity. Metabolism. 2010;59:186–194.
   PubMed Web of Science ®Google Scholar
• Muller HL. Childhood craniopharyngioma - current status and recent perspectives in diagnostics and treatment. J Pediatr Endocrinol Metab. 2015;28:1–2.
   PubMed Web of Science ®Google Scholar
• Kalina MA, Wilczek M, Kalina-Faska B, et al. Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience. J Pediatr Endocrinol Metab. 2015;28:45–51.
   PubMed Web of Science ®Google Scholar
• Zoicas F, Droste M, Mayr B, et al. GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases. Eur J endocrinol/Eur Fed Endocr Soc. 2013;168:699–706.
   PubMed Web of Science ®Google Scholar
• van Santen HM, Schouten-Meeteren AY, Serlie M, et al. Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity. J Pediatr Endocrinol Metab. 2015;28:53–57.
   PubMed Web of Science ®Google Scholar
• Profka E, Giavoli C, Bergamaschi S, et al. Analysis of short- and long-term metabolic effects of growth hormone replacement therapy in adult patients with craniopharyngioma and non-functioning pituitary adenoma. J Endocrinol Invest. 2015;38:413–420.
   PubMed Web of Science ®Google Scholar
• Yuen KC, Koltowska-Haggstrom M, Cook DM, et al. Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction. Eur J endocrinol/Eur Fed Endocr Soc. 2013;169:511–519.
   PubMed Web of Science ®Google Scholar
• Lustig RH, Hinds PS, Ringwald-Smith K, et al. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2003;88:2586–2592.
   PubMed Web of Science ®Google Scholar
• Bretault M, Boillot A, Muzard L, et al. Clinical review: bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis. J Clin Endocrinol Metab. 2013;98:2239–2246.
   PubMed Web of Science ®Google Scholar
• Gatta B, Nunes ML, Bailacq-Auder C, et al. Is bariatric surgery really inefficient in hypothalamic obesity? Clin Endocrinol (Oxf). 2013;78:636–638.
   PubMed Web of Science ®Google Scholar
• Muller HL, Gebhardt U, Wessel V, et al. First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. Klin Padiatr. 2007;219:323–325.
   PubMed Web of Science ®Google Scholar
• Muller HL, Gebhardt U, Maroske J, et al. Long-term follow-up of morbidly obese patients with childhood craniopharyngioma after laparoscopic adjustable gastric banding (LAGB). Klin Padiatr. 2011;223:372–373.
   PubMed Web of Science ®Google Scholar
• Zonca P, Hoppe C, Cambal M, et al. Gastric stimulation in treatment in type 2 diabetes mellitus. Bratisl Lek Listy. 2014;115:34–37.
   PubMed Web of Science ®Google Scholar
• Ho AL, Sussman ES, Zhang M, et al. Deep brain stimulation for obesity. Cureus. 2015;7:e259.
   PubMedGoogle Scholar
• Gump JM, Donson AM, Birks DK, et al. Identification of targets for rational pharmacological therapy in childhood craniopharyngioma. Acta Neuropathol Commun. 2015;3:30.
   PubMed Web of Science ®Google Scholar
• Sterkenburg AS, Hoffmann A, Gebhardt U, et al. [Childhood craniopharyngioma with hypothalamic obesity - no long-term weight reduction due to rehabilitation programs]. Klin Padiatr. 2014;226:344–350.
   PubMed Web of Science ®Google Scholar
• Nemergut DR, Townsend AR. The importance of interdisciplinary communication with patients about complex, chronic illnesses: our experiences as parents of a child with a craniopharyngioma. J Pediatr Endocrinol Metab. 2015;28:3–5.
   PubMed Web of Science ®Google Scholar
• Meijneke RW, Schouten-van Meeteren AY, de Boer NY, et al. Hypothalamic obesity after treatment for craniopharyngioma: the importance of the home environment. J Pediatr Endocrinol Metab. 2015;28:59–63.
   PubMed Web of Science ®Google Scholar
• Hoffmann A, Postma FP, Sterkenburg AS, et al. Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma. J Pediatr Endocrinol Metab. 2015;28:35–43.
   PubMed Web of Science ®Google Scholar
• Roth CL, Aylward E, Liang O, et al. Functional neuroimaging in craniopharyngioma: a useful tool to better understand hypothalamic obesity? Obes Facts. 2012;5:243–253.
   PubMed Web of Science ®Google Scholar
• Roemmler-Zehrer J, Geigenberger V, Stormann S, et al. Specific behaviour, mood and personality traits may contribute to obesity in patients with craniopharyngioma. Clin Endocrinol (Oxf). 2015;82:106–114.
   PubMed Web of Science ®Google Scholar
• Holmer H, Pozarek G, Wirfält E, et al. Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. J Clin Endocrinol Metab. 2010;95:5395–5402.
   PubMed Web of Science ®Google Scholar
• Hoffmann A, Gebhardt U, Sterkenburg AS, et al. Diencephalic syndrome in childhood craniopharyngioma-results of german multicenter studies on 485 long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metab. 2014;99:3972–3977.
   PubMed Web of Science ®Google Scholar
• Daubenbuchel AM, Hoffmann A, Gebhardt U, et al. Hydrocephalus and hypothalamic involvement in pediatric patients with craniopharyngioma or cysts of Rathke’s pouch: impact on long-term prognosis. Eur J endocrinol/Eur Fed Endocr Soc. 2015;172:561–569.
   PubMed Web of Science ®Google Scholar
• Pickering L, Jennum P, Gammeltoft S, et al. Sleep-wake and melatonin pattern in craniopharyngioma patients. Eur J endocrinol/Eur Fed Endocr Soc. 2014;170:873–884.
   PubMed Web of Science ®Google Scholar
• Ozyurt J, Thiel CM, Lorenzen A, et al. Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement. J Pediatr. 2014;164(876–881):e874.
   Google Scholar
• Ozyurt J, Lorenzen A, Gebhardt U, et al. Remote effects of hypothalamic lesions in the prefrontal cortex of craniopharygioma patients. Neurobiol Learn Mem. 2014;111:71–80.
   PubMed Web of Science ®Google Scholar
• Ozyurt J, Muller HL, Thiel CM. A systematic review of cognitive performance in patients with childhood craniopharyngioma. J Neurooncol. 2015;125:9–21.
   PubMed Web of Science ®Google Scholar
• Zada G, Kintz N, Pulido M, et al. Prevalence of neurobehavioral, social, and emotional dysfunction in patients treated for childhood craniopharyngioma: a systematic literature review. Plos One. 2013;8:e76562.
   PubMed Web of Science ®Google Scholar
• Crespo I, Santos A, Webb SM. Quality of life in patients with hypopituitarism. Curr Opin Endocrinol Diabetes Obes. 2015;22:306–312.
   PubMed Web of Science ®Google Scholar
• Crespo I, Valassi E, Santos A, et al. Health-related quality of life in pituitary diseases. Endocrinol Metab Clin North Am. 2015;44:161–170.
   PubMed Web of Science ®Google Scholar
• Hoffmann A, Bootsveld K, Gebhardt U, et al. Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma. Eur J endocrinol/Eur Fed Endocr Soc. 2015;173:389–397.
   PubMed Web of Science ®Google Scholar
• Muller HL. Craniopharyngioma: long-term consequences of a chronic disease. Expert Rev Neurother. 2015;15:1241–1244.
   PubMed Web of Science ®Google Scholar